Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Semiconductor ETF (SOXX) vs Twist Bioscience Corp (TWST) Price & Performance

iShares Semiconductor ETFTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

iShares Semiconductor ETF vs Twist Bioscience Corp — how do they compare? iShares Semiconductor ETF trades at $551.77, while Twist Bioscience Corp trades at $124.79 (market cap $7.72B). The key difference: Twist Bioscience Corp is trading nearer its 52-week high, iShares Semiconductor ETF nearer its low. Which is the better fit depends on your goals.

SOXXTWST
Sector
Sector/ThematicHealth
52-Week High
$655.01$124.88
52-Week Low
$241.68$24.16
Market Cap
$7.72B
Enterprise Value
$7.65B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Semiconductor ETF

SOXX, the iShares Semiconductor ETF, trades at $550.61, up 3.88% in the last session, with a bullish technical signal driven by moving averages. Recent news highlights sector volatility, including a 21% plunge in July due to headwinds like short-seller commentary and competitive pressures, though major cloud company growth supports AI spending optimism. The ETF's concentration in 30 semiconductor stocks contrasts with broader tech diversification options.

Outlook hinges on semiconductor demand from AI and data centers, with potential from U.S. policy support, but risks include tariff impacts, high valuation concerns, and sector rotation. Investors face trade-offs between SOXX's focused exposure and broader, lower-fee alternatives amid ongoing market efficiency and inflow trends.

Twist Bioscience Corp

Twist Bioscience (TWST) trades at $123.76, down 0.9% on the day, with a bullish technical signal from moving averages but bearish oscillators. Revenue growth is strong, with 2025 revenue at $376.57 million, though the company remains unprofitable with a net income margin of -31.66%. Recent news highlights an upsized $300 million public offering and an analyst upgrade, contributing to positive sentiment.

The outlook is mixed: robust revenue growth and high analyst buy ratings (78.57%) support upside potential, but persistent losses, negative cash flow, and high valuation ratios pose significant risks. Investors should weigh the growth trajectory against the path to profitability and cash burn concerns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares Semiconductor ETF

SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.

Read more on SOXX

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST